|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.910 CNY | +3.87% |
|
+5.16% | -19.81% |
| 06-02 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 6.07B 900M 778M 727M 667M 1.25B 85.62B 1.27B 8.53B 3.35B 42.92B 3.38B 3.3B 142B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.93B 731M 632M 590M 541M 1.02B 69.53B 1.03B 6.92B 2.72B 34.85B 2.74B 2.68B 115B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | +3.87% | ||
| 1 week | +5.16% | ||
| Current month | +5.16% | ||
| 1 month | +1.37% | ||
| 3 months | -10.45% | ||
| 6 months | -10.45% | ||
| Current year | -19.81% |
| 1 week | 5.53 |  | 5.91 |
| 1 month | 5.2 | | 7.33 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.87% | +5.16% | -26.86% | -35.48% | 900M | |
| -0.52% | +3.21% | +85.02% | +161.12% | 1,057B | |
| +0.88% | +1.13% | +51.13% | +49.76% | 625B | |
| +0.89% | -1.95% | +23.73% | +63.67% | 435B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 363B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 296B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 249B | |
| +1.51% | +6.69% | +44.34% | +62.47% | 222B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 209B | |
| +1.80% | +2.30% | +20.79% | +65.13% | 165B | |
| Average | +1.57% | +1.22% | +28.84% | +41.08% | 362.17B | |
| Weighted average by Cap. | +1.12% | +1.22% | +48.32% | +75.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.86M 84.65M 79.05M 72.52M 136M 9.31B 139M 927M 364M 4.67B 367M 359M 15.43B | 624M 92.41M 79.94M 74.65M 68.48M 129M 8.79B 131M 876M 344M 4.41B 347M 339M 14.57B |
| Net income | -74.07M -10.97M -9.49M -8.87M -8.13M -15.3M -1.04B -15.54M -104M -40.82M -524M -41.21M -40.31M -1.73B | -347M -51.45M -44.5M -41.56M -38.12M -71.71M -4.9B -72.84M -488M -191M -2.45B -193M -189M -8.11B |
| Net Debt | -1.98B -294M -254M -237M -218M -409M -27.95B -416M -2.78B -1.09B -14.01B -1.1B -1.08B -46.32B | -1.14B -169M -146M -137M -125M -236M -16.1B -239M -1.6B -629M -8.07B -635M -621M -26.67B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | CN¥5.910 | +3.87% | 49,384,899 |
| 06/08/26 | CN¥5.690 | -0.70% | 25,922,832 |
| 05/08/26 | CN¥5.730 | -0.52% | 26,667,697 |
| 04/08/26 | CN¥5.760 | +1.77% | 27,750,660 |
| 03/08/26 | CN¥5.660 | +0.71% | 19,909,637 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
